Neurocognitive Disorder

The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists for obesity and diabetes, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

The FDA has declined to approve a new drug application for roluperidone to treat negative symptoms in individuals with schizophrenia.

Adults diagnosed with HF before age 65 years were 67% more likely to be diagnosed with dementia during 12 years of follow-up compared with adults diagnosed at age 75 years or older, suggesting careful neurocognitive monitoring is needed.

Infection-specific processes, rather than general systemic inflammation, may play a role in the development of dementia among those with hospital-diagnosed infections, according to research from JAMA Network Open.

Stressors in life can contribute to poor functional, cognitive and neuropsychiatric outcomes up to a year after being hospitalized with COVID-19, researchers reported in the Journal of Neurological Science.

Patients with neurocognitive disorders often receive a late diagnosis due to the lack of affordable and time-efficient screening methods. Researchers are considering ocular biomarkers as a solution to this issue.

In this video exclusive, Alice Bast and Jessica Edwards George, PhD, discussed a study assessed how brain fog and other neurocognitive symptoms impact patients with celiac disease.

Adults with congenital heart disease demonstrated poorer neurocognitive function compared with those without it, according to research published in the Journal of the American Heart Association.

Children with mild and persistent untreated subclinical hypothyroidism did not have impaired neurocognitive function and did not see neurocognitive benefits from 2 years of levothyroxine therapy, according to findings from a case-control study reported in The Journal of Clinical Endocrinology & Metabolism.